What is the recommended method of administration for injection amiodarone (antiarrhythmic medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Method of Administration for Intravenous Amiodarone

Administer IV amiodarone through a central venous catheter whenever possible using a volumetric infusion pump with an in-line filter, diluted in D5W at concentrations not exceeding 2 mg/mL for peripheral access or infusions longer than 1 hour. 1

Route and Access Requirements

  • Use a central venous catheter dedicated to amiodarone administration whenever possible to minimize the risk of severe peripheral vein phlebitis, which occurs frequently with concentrations >2 mg/mL 1
  • For concentrations >2 mg/mL, a central line is mandatory 2
  • Peripheral venous access may be used only if concentrations are ≤2 mg/mL and infusion duration is ≤1 hour 1

Infusion Equipment and Preparation

  • Amiodarone must be delivered by a volumetric infusion pump - never use drop counter infusion sets, as altered surface properties can reduce drop size and cause up to 30% underdosing 1
  • Use an in-line filter during all administrations 1
  • Administer infusions exceeding 2 hours in glass or polyolefin bottles containing D5W only 1
  • Do not use evacuated glass containers for admixing, as buffer incompatibility may cause precipitation 1

Standard Dosing Protocol for Life-Threatening Ventricular Arrhythmias

Initial Loading (First 24 Hours)

  • Loading dose: 150 mg IV over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for the remaining 18 hours (total ~1000 mg over 24 hours) 2, 1
  • Do not exceed an initial infusion rate of 30 mg/min 1
  • Mean daily doses above 2100 mg are associated with increased risk of hypotension 1

Maintenance Infusion (After 24 Hours)

  • Continue at 0.5 mg/min (720 mg per 24 hours) using concentrations of 1-6 mg/mL 1
  • Maintenance infusion up to 0.5 mg/min can be continued for 2-3 weeks regardless of age, renal function, or left ventricular function 1

Breakthrough Arrhythmias

  • For breakthrough VF or hemodynamically unstable VT: administer 150 mg supplemental bolus mixed in 100 mL D5W infused over 10 minutes 1

Cardiac Arrest Protocol (VF/Pulseless VT)

  • For cardiac arrest unresponsive to defibrillation and epinephrine: 300 mg IV/IO bolus over 10 minutes, with a second 150 mg bolus if rhythm persists 2
  • In pediatric patients: 5 mg/kg rapid bolus (maximum 300 mg) IV/IO, may repeat up to total daily dose of 15 mg/kg 3

Critical Monitoring Requirements

  • Continuous ECG monitoring is mandatory during all amiodarone administration to detect bradycardia (occurs in 4.9% of IV patients), AV block, heart block, QT prolongation, and hypotension (occurs in 16% of IV patients) 2, 4
  • A defibrillator must be immediately available 3
  • Monitor blood pressure continuously during loading doses 2
  • Watch for phlebitis at infusion site, particularly with peripheral access 2

Absolute Contraindications

  • Do not administer without a pacemaker in patients with: second- or third-degree AV block, sick sinus syndrome, or severe sinus node dysfunction 3, 4
  • Contraindicated in patients who have had a heart transplant 3

Important Administration Caveats

  • Amiodarone adsorbs to PVC tubing, but all clinical dosing recommendations account for this effect 1
  • The drug leaches plasticizers (DEHP) from IV tubing, particularly at higher concentrations and lower flow rates 1
  • Amiodarone does not require light protection during administration 1
  • Inspect solution before administration - it should be clear 1
  • Never use plastic containers in series connections, as this can cause air embolism 1

Common Pitfalls to Avoid

  • Loading infusions at concentrations and rates much higher than recommended have resulted in hepatocellular necrosis, acute renal failure, and death 1
  • Concentrations >3 mg/mL in D5W are associated with high incidence of peripheral vein phlebitis 1
  • If bradycardia or heart block develops, discontinue the infusion or reduce the rate immediately 4
  • Reduce digoxin dose by 50% when starting amiodarone, as digoxin levels predictably double 4
  • Reduce warfarin dose by 30-50% and check INR within 3-5 days, as amiodarone significantly increases anticoagulation effects 4

References

Guideline

Amiodarone Infusion Protocol for Life-Threatening Ventricular Arrhythmias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Administering IV Amiodarone with Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.